Cross presentation of antigen by dendritic cells: Mechanisms and implications for immunotherapy

Expert Review of Clinical Immunology

Volumn 8, Issue 6, 2012, Pages 547-555

  Sachamitr, Patty ^a   Fairchild, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

antigen presentation; CD141; CD8 + DC; cross presentation; dendritic cells; immunotherapy; XCR1

Indexed keywords

ANTIGEN;

AUTOIMMUNE DISEASE; CELL SUBPOPULATION; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; NEOPLASM; NONHUMAN; REVIEW;

ANTIGEN PRESENTATION; CROSS-PRIMING; DENDRITIC CELLS; HUMANS;

EID: 84866703402     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.45     Document Type: Review

References (74)

1. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143(5), 1283-1288 (1976).
2. Allan RS, Smith CM, Belz GT et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301(5641), 1925-1928 (2003).
3. Van Kaer L. Major histocompatibility complex class I-restricted antigen processing and presentation. Tissue Antigens 60(1), 1-9 (2002).
4. Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat. Rev. Immunol. 10(6), 403-414 (2010).
5. Heath WR, Carbone FR. Crosspresentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1(2), 126-134 (2001).
6. Smith CM, Belz GT, Wilson NS et al. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170(9), 4437-4440 (2003).
7. Belz GT, Shortman K, Bevan MJ, Heath WR. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175(1), 196-200 (2005).
8. Merkenschlager M, Power MO, Pircher H, Fisher AG. Intrathymic deletion of MHC class I-restricted cytotoxic T cell precursors by constitutive cross-presentation of exogenous antigen. Eur. J. Immunol. 29(5), 1477-1486 (1999).
9. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted crosspresentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186(2), 239-245 (1997).
10. Bachem A, Güttler S, Hartung E et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207(6), 1273-1281 (2010).
11. Segura E, Villadangos JA. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic 12(12), 1677-1685 (2011).
12. Neijssen J, Herberts C, Drijfhout JW, Reits E, Janssen L, Neefjes J. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434(7029), 83-88 (2005).
13. Palmowski MJ, Gileadi U, Salio M et al. Role of immunoproteasomes in crosspresentation. J. Immunol. 177(2), 983-990 (2006).
14. Flinsenberg TW, Compeer EB, Boelens JJ, Boes M. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin. Exp. Immunol. 165(1), 8-18 (2011).
15. Belizaire R, Unanue ER. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc. Natl Acad. Sci. USA 106(41), 17463-17468 (2009).
16. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267(5195), 243-246 (1995).
17. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1(6), 362-368 (1999).
18. Tsai B, Ye Y, Rapoport TA. Retrotranslocation of proteins from the endoplasmic reticulum into the cytosol. Nat. Rev. Mol. Cell Biol. 3(4), 246-255 (2002).
19. Jarosch E, Taxis C, Volkwein C et al. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 4(2), 134-139 (2002).
20. Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25(4), 607-617 (2006).
21. Koopmann JO, Albring J, Hüter E et al. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 13(1), 117-127 (2000).
22. Imai T, Kato Y, Kajiwara C et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc. Natl Acad. Sci. USA 108(39), 16363-16368 (2011).
23. Ichiyanagi T, Imai T, Kajiwara C et al. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation. J. Immunol. 185(5), 2693-2700 (2010).
24. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307(5715), 1630-1634 (2005).
25. Savina A, Jancic C, Hugues S et al. NOX2 controls phagosomal pH to regulate antigen processing during cross presentation by dendritic cells. Cell 126(1), 205-218 (2006).
26. Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I cross presentation in vivo. Immunity 21(2), 155-165 (2004).
27. Huang AY, Bruce AT, Pardoll DM, Levitsky HI. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4(4), 349-355 (1996).
28. Firat E, Saveanu L, Aichele P et al. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J. Immunol. 178(4), 2241-2248 (2007).
29. Ackerman AL, Kyritsis C, Tampé R, Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl Acad. Sci. USA 100(22), 12889-12894 (2003).
30. Houde M, Bertholet S, Gagnon E et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425(6956), 402-406 (2003).
31. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425(6956), 397-402 (2003).
32. Gagnon E, Duclos S, Rondeau C et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110(1), 119-131 (2002).
33. Müller-Taubenberger A, Lupas AN, Li H, Ecke M, Simmeth E, Gerisch G. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20(23), 6772-6782 (2001).
34. Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3(4), 280-291 (2003).
35. Touret N, Paroutis P, Terebiznik M et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123(1), 157-170 (2005).
36. Cebrian I, Visentin G, Blanchard N et al. Sec22b regulates phagosomal maturation and antigen cross presentation by dendritic cells. Cell 147(6), 1355-1368 (2011).
37. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270(3), 1443-1448 (1995).
38. Vigna JL, Smith KD, Lutz CT. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J. Immunol. 157(10), 4503-4510 (1996).
39. Basha G, Omilusik K, Chavez-Steenbock A et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nat. Immunol. 13(3), 237-245 (2012).
40. Bertholet S, Goldszmid R, Morrot A et al. Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J. Immunol. 177(6), 3525-3533 (2006).
41. Saveanu L, Carroll O, Weimershaus M et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325(5937), 213-217 (2009).
42. Lizée G, Basha G, Tiong J et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4(11), 1065-1073 (2003).
43. Basha G, Lizée G, Reinicke AT, Seipp RP, Omilusik KD, Jefferies WA. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells. PLoS ONE 3(9), e3247 (2008).
44. Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat. Immunol. 9(5), 558-566 (2008).
45. Segura E, Albiston AL, Wicks IP, Chai SY, Villadangos JA. Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc. Natl Acad. Sci. USA 106(48), 20377-20381 (2009).
46. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2(3), 151-161 (2002).
47. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7(7), 543-555 (2007).
48. den Haan JM, Lehar SM, Bevan MJ. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192(12), 1685-1696 (2000).
49. Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195(10), 1289-1302 (2002).
50. Schulz O, Reis e Sousa C. Crosspresentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107(2), 183-189 (2002).
51. Edwards AD, Diebold SS, Slack EM et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33(4), 827-833 (2003).
52. Dorner BG, Dorner MB, Zhou X et al. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity 31(5), 823-833 (2009).
53. Reis e Sousa C, Hieny S, Scharton-Kersten T et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186(11), 1819-1829 (1997).
54. Hildner K, Edelson BT, Purtha WE et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322(5904), 1097-1100 (2008).
55. Crozat K, Guiton R, Contreras V et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207(6), 1283-1292 (2010).
56. Jongbloed SL, Kassianos AJ, McDonald KJ et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207(6), 1247-1260 (2010).
57. Robbins SH, Walzer T, Dembélé D et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9(1), R17 (2008).
58. Caminschi I, Proietto AI, Ahmet F et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112(8), 3264-3273 (2008).
59. Lei Y, Takahama Y. XCL1 and XCR1 in the immune system. Microbes Infect. 14(3), 262-267 (2012).
60. Villadangos JA, Shortman K. Found in translation: the human equivalent of mouse CD8+ dendritic cells. J. Exp. Med. 207(6), 1131-1134 (2010).
61. Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigenprocessing dendritic cells. J. Exp. Med. 198(2), 235-247 (2003).
62. Heath WR, Belz GT, Behrens GM et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26 (2004).
63. Kurts C, Carbone FR, Barnden M et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186(12), 2057-2062 (1997).
64. Smith CM, Wilson NS, Waithman J et al. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5(11), 1143-1148 (2004).
65. Holtappels R, Podlech J, Pahl-Seibert MF et al. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J. Exp. Med. 199(1), 131-136 (2004).
66. Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity 33(4), 464-478 (2010).
67. Poulin LF, Salio M, Griessinger E et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 207(6), 1261-1271 (2010).
68. Cravens PD, Melkus MW, Padgett-Thomas A, Islas-Ohlmayer M, Del P Martin M, Garcia JV. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells 23(2), 264-278 (2005).
69. Fairchild PJ, Waldmann H. Dendritic cells and prospects for transplantation tolerance. Curr. Opin. Immunol. 12(5), 528-535 (2000).
70. Senju S, Hirata S, Matsuyoshi H et al. Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood 101(9), 3501-3508 (2003).
71. Zhan X, Dravid G, Ye Z et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 364(9429), 163-171 (2004).
72. Tseng SY, Nishimoto KP, Silk KM et al. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. Regen. Med. 4(4), 513-526 (2009).
73. Silk KM, Silk JD, Ichiryu N et al. Crosspresentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1(+) dendritic cells. Gene Ther. doi:10.1038/gt.2011.177 (2011) (Epub ahead of print).
74. Senju S, Hirata S, Motomura Y et al. Pluripotent stem cells as source of dendritic cells for immune therapy. Int. J. Hematol. 91(3), 392-400 (2010).